| Title : Re-Profiling and Re-purposing of FDA-Approved AntiViral Agents Against Neurological Targets of Memory and Cognition: Molecular Docking and Simulation Approach - Naeem_2026_CNS.Neurol.Disord.Drug.Targets__ |
| Author(s) : Naeem MU , Khan Y , Costa RAD , Khan SS , Faheem M |
| Ref : CNS Neurol Disord Drug Targets , : , 2026 |
| Abstract : |
| PubMedSearch : Naeem_2026_CNS.Neurol.Disord.Drug.Targets__ |
| PubMedID: 42136300 |